Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Merus NV MRUS

Healthcare Biotechnology
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's... see more

Recent & Breaking News (NDAQ:MRUS)

Merus Announces Pricing of Public Offering of Common Shares

GlobeNewswire January 21, 2021

Merus N.V. Announces Proposed Public Offering of Common Shares

GlobeNewswire January 19, 2021

Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies

PR Newswire January 19, 2021

Merus Announces Collaborations with Nationwide Medical Organizations in the Netherlands and Japan to Enhance Screening and Identification of Cancer Patients with NRG1 Fusion Tumors and to Raise Awareness of the eNRGy Clinical Trial

GlobeNewswire January 12, 2021

Merus Announces Presentation of Phase 1 Clinical Data for MCLA-158 at the American Society of Clinical Oncology (ASCO) 2021 Gastrointestinal Cancers Symposium

GlobeNewswire January 11, 2021

Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers

GlobeNewswire January 7, 2021

Merus and Sema4 Enter Into an Agreement to Support Merus' Phase 1/2 Clinical Trial of Zenocutuzumab

GlobeNewswire December 17, 2020

Merus to Present at the Jefferies Virtual London Healthcare Conference

GlobeNewswire November 16, 2020

Merus Announces Poster Presentations on MCLA-145 at Society for Immunotherapy of Cancer

GlobeNewswire November 9, 2020

Merus Announces Financial Results for the Third Quarter and Provides Business Update

GlobeNewswire November 5, 2020

Merus and myTomorrows Announce Expansion of Collaboration for Screening and eNRGy Clinical Trial Awareness for Cancer Patients with Neuregulin 1 Fusion Tumors

GlobeNewswire October 12, 2020

Merus to Present at the 2020 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 7, 2020

Merus Announces Financial Results for the Second Quarter and Provides Business Update

Thomson Reuters ONE August 6, 2020

Merus announces FDA Orphan Drug Designation of Zenocutuzumab for the Treatment of Pancreatic Cancer

GlobeNewswire July 27, 2020

Merus Appoints Andrew Joe, M.D., as Chief Medical Officer

GlobeNewswire July 27, 2020

Merus and Caris Life Sciences Announce Collaboration to Detect NRG1 Fusions in Cancer Patients

GlobeNewswire July 13, 2020

Merus to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference

GlobeNewswire June 1, 2020

Merus Announces the Acceptance of Six Abstracts at Upcoming Medical Conferences and Provides Program Updates

GlobeNewswire May 14, 2020

Merus Announces Financial Results for the First Quarter and Provides Business Update

Thomson Reuters ONE May 11, 2020

Merus Announces Financial Results for the Fourth Quarter and Full Year 2019 and Provides Business Update

GlobeNewswire March 12, 2020